Entrectinib Capsules
$50.00
Entrectinib Capsules are a kinase inhibitor used for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive.
Entrectinib Capsules are also used for adult and pediatric patients aged 12 years and older with NTRK fusion-positive solid tumors.
Recommended Dosage: The recommended dosage for ROS1-Positive Non-Small Cell Lung Cancer is 600 mg orally once daily with or without food until disease progression or unacceptable toxicity.
The recommended dosage for NTRK Gene Fusion-Positive Solid Tumors in adults is 600 mg orally once daily, and for Pediatric Patients aged 12 years and older (Adolescents) with Body Surface Area (BSA) greater than 1.50 m2 dose is 600 mg; for BSA 1.11 to 1.50 m2 dose is 500 mg and for BSA 0.91 to 1.10 m2 dose is 400 mg. Take this medicine orally once daily with or without food until the disease is progressive or unacceptable toxicity occurs.
- Free delivery over 00
- 30 Days Return Period
Customer Reviews
There are no reviews yet.